HeartBeam, Inc. (BEAT)
NASDAQ: BEAT · Real-Time Price · USD
1.020
-0.110 (-9.73%)
At close: Aug 1, 2025, 4:00 PM
1.070
+0.050 (4.90%)
After-hours: Aug 1, 2025, 6:14 PM EDT
HeartBeam Market Cap
HeartBeam has a market cap or net worth of $34.49 million as of August 1, 2025. Its market cap has decreased by -54.99% in one year.
Market Cap
34.49M
Enterprise Value
27.69M
1-Year Change
-54.99%
Ranking
Category
Stock Price
$1.02
Market Cap Chart
Since the IPO on November 11, 2021, HeartBeam's market cap has decreased from $46.53M to $34.49M, a decrease of -25.88%. That is a compound annual growth rate of -7.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 38.20M | -38.41% |
| Dec 31, 2024 | 62.04M | 0.26% |
| Dec 29, 2023 | 61.87M | 58.40% |
| Dec 30, 2022 | 39.06M | 62.39% |
| Dec 31, 2021 | 24.05M | -48.30% |
| Nov 11, 2021 | 46.53M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |